Dosage amounts create similar improvement in C. diff cases


High and low dosages of a popular antibiotic offer little difference in the outcomes of Clostridium difficile infections, according to a new study.

HIV patients living longer, requiring different care from LTC providers, report says


Healthcare providers should offer testing for human immunodeficiency virus (HIV) in older adults and adjust care for those who have the disease, a new study reports.

New approach to Alzheimer's treatment might be key to a cure


Alzheimer's disease detection should start earlier, even before loss of cognitive function, a professor of medical ethics said Monday. In a webinar, Jason Karlawish, M.D., and Richard W. Besdine, M.D., discussed new approaches to Alzheimer's treatment and prevention, which they said has drastically changed since the disease was first discovered in the early 20th century.

Researchers make 'stunning' Alzheimer's breakthrough, return affected neurons to normal state


A major breakthrough in Alzheimer's research could lead to new and more effective ways of treating the disease, according to a recently released study in the Journal of Neuroscience.

Bacteria mix offers hope for those with C. diff


Researchers have hit on a potentially novel way to fight Clostridium difficile: a cocktail of six different types of bacteria.

Jump in painkiller sales provoke worries about addiction, regulations


A huge rise in the use of oxycodone over the past decade has led to increasing worries about the number of addicts and a lack of places to treat them.

Good nursing care and laughter called important for treating hard-to-heal leg ulcers

Advanced technological approaches to treating venous leg ulcers are no match for good quality nursing care and a few good jokes, new research suggests.

Rheumatoid arthritis treatments for seniors called 'unacceptable'

More than one-third of 93,000 Medicare managed care enrollees who received care for rheumatoid arthritis in recent years did not receive recommended drugs, according to researchers. In addition, the quality of drug treatments varied among geographic areas, socio-economic groups and health plans. Study results appeared in Wednesday's issue of the Journal of the American Medical Association.

Alzheimer's costs could reach $20 trillion by 2050 if no treatment is found, report finds

Alzheimer's costs could reach $20 trillion by 2050 if no treatment is found, report finds

Without an effective treatment, the cumulative costs of caring for patients with Alzheimer's disease in the United States could top $20 trillion over the next 40 years, according to a new report from the Alzheimer's Association.

As patients age, their choices mean less to their doctors, report finds

Doctors of elderly patients who are incapable of making decisions are more likely to choose treatment that they believe is in the best interest of their patients, and not necessarily the treatment their patients would have wanted.

Researchers looking to extra-virgin olive oil for possible recipe against Alzheimer's

Extra-virgin olive oil (or E.V.O.O. to fans of cooking show host Rachael Ray) is heart-healthy cooking oil that goes great with Mediterranean food. Now, researchers say it might also help prevent Alzheimer's disease.